Abstract
A total of 102 Candida species were isolated from blood cultures from January 1997 to October 1999. Using assimilation of carbohydrate test, 52 (51.0%) of the Candida sp. were identified as C. parapsilosis, 25.5% (26) were C. tropicalis. C. albicans made up 11.8% (12), 6.9% (7) were C. rugosa, 3.8% (4) C. glabrata and 1% (1) C. guilliermondii. No C. dubliniensis was found in the study. In vitro antifungal susceptibility tests showed that all Candida species were sensitive to nystatin, amphotericin B and ketoconazole. Although all isolates remained sensitive to fluconazole, intermediate susceptibility was found in 3 C. rugosa isolates. Antifungal agents with high frequency of resistance were econazole, clotrimazole, miconazole and 5-fluorocytosine. Candida species found to have resistance to these antifungal agents were non-C. albicans.
Similar content being viewed by others
References
Jarvis WR. Epidemiology of nosocomial fungal infections, with emphasis on Candida species. Clin Infect Dis 1995; 20: 1526-1530.
Kossoff EH, Buescher ES, Karlowicz MG. Candidemia in a neonatal intensive care unit: trends during fifteen years and clinical features of 111 cases. Pediatr Infect Dis J 1998; 17(6): 504-508.
Sasse KC, Nauenberg E, Long A, Anton B, Tucker HJ, Hu TW. Long term survival after intensive care unit admission with sepsis. Crit Care Med 1995; 23: 1040-1047.
Wey, SB, Mori M, Pfaller MA, Woolson RF, Wenzel RP. Risk factors for hospital-acquired candidemia. A matched case-control study. Arch Intern Med 1989; 149: 2349-2353.
Ng KP, Madasamy M, Saw TL, Baki A, He J, Soo-Hoo TS. Candida biotypes isolated from clinical specimens in Malaysia. Mycopathologia 1999; 144: 135-140.
Chakrabarti A, Chander J, Kasturi P, Panigrahi D. Candidaemia: a 10-year study in an Indian teaching hospital. Mycoses 1992; 35(1-2): 47-51.
Krcmery V Jr, Spanik S, Grausova S, Trupl J, Krupova I, Roidova A, Salek T, Sufliarsky J, Mardiak J. Candida parapsilosis fungemia in cancer patients-incidence, risk factors and outcome. Neoplasma 1998; 45(5): 336-342.
Levy I, Rubin LG, Vasishtha S, Tucci V, Sood SK. Emergence of Candida parapsilosis as the predominant species causing candidemia in children. Clin Infect Dis 1998; 26(5): 1086-1088.
Abi-Said D, Anaissie E, Uzun O, Raad I, Pinzcowski H, Vartivarian S. The epidemiology of hematogenous candidiasis caused by different Candida species. Clin Infect Dis 1997; 24(6): 1122-1128.
Weinberger M, Sacks T, Sulkes J, Shapiro M, Polacheck I. Increasing fungal isolation from clinical specimens: experience in a university hospital over a decade. J Hosp Infect 1997; 35(3): 185-195.
Voss A, le Boble JL, Verduyn Lunel FM, Foudraine NA, Meis JF. Candidemia in intensive care unit patients: risk factors for mortality. Infection 1997; 25(1): 8-11.
Nguyen MH, Peacock JE Jr, Morris AJ, Tanner DC, Nguyen ML, Snydman DR, Wagener NM, Rinaldi MG, Yu VL. The changing face of candidemia: emergence of non-Candidia albicans species and antifungal resistance.Am J Med 1996; 100(6): 617-623.
Kiehn TE, Edwards FF, Armstrong D. The prevalence of yeasts in clinical specimens from cancer patients. Am J Clin Pathol 1980; 73(4): 518-521.
Merz WG, Karp JE, Schron D, Saral R. Increased incidence of fungemia caused by Candida krusei. J Clin Microbiol 1986; 24(4): 581-584.
Abrahamsen TG, Widing E, Glomstein A, Gaustad P. Disseminated fungal disease resistant to fluconazole treatment in a child with leukaemia. Scand J Infect Dis 1992; 24: 391-393.
Krcmery V Jr, Oravcova E, Spanik S, Mrazova-Studena M, Trupi J, Kunova A, Stopkova-Grey K, Kuikuckova E, Krupova I, Demitrovicova A, Kralovicova K. Nosocomial breakthrough fungaemia during antifungal prophylaxis or empirical antifungal therapy in 41 cancer patients receiving antineoplastic chemotherapy: analysis of aetiology risk factors and outcome. J Antimicrob Chemother 1999; 41(3): 373-380.
Nolte FS, Parkinson T, Falconer DJ, Dix S, Williams J, Gilmore C, Geller R, Wingard JR. Isolation and characterization of fluconazole-and amphotericin B resistant Candida albicans from blood of two patients with leukaemia. Antimicrob Agents Chemother 1997; 41(1): 196-199.
Sandford GR, Merz WG, Wingard JR, Charache P, Saral R. The value of fungal surveillance cultures as predictors of systemic infections. J Infect Dis 1980; 142: 503-509.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ng, K., Saw, T., Na, S. et al. Systemic Candida infection in University Hospital 1997–1999: the distribution of Candida biotypes and antifungal susceptibility patterns. Mycopathologia 149, 141–146 (2001). https://doi.org/10.1023/A:1007283211220
Issue Date:
DOI: https://doi.org/10.1023/A:1007283211220